Skip to main content
Clinical Trials/NCT04786314
NCT04786314
Unknown
Not Applicable

The Effect of Hot and Cold Water Application to Pregnant Women With Restless Legs Syndrome on Complaints and Quality of Sleep

TC Erciyes University1 site in 1 country90 target enrollmentSeptember 30, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Restless Legs Syndrome
Sponsor
TC Erciyes University
Enrollment
90
Locations
1
Primary Endpoint
RLS Severity Rating Scale
Last Updated
5 years ago

Overview

Brief Summary

This study was planned as a randomized controlled study to determine the effect of hot and cold water application on complaints and sleep quality in pregnant women with restless legs syndrome (RLS). Pregnant women with a total of 90 RLS, including 30 people in each group, will be included in the study. The data of this study will be collected by Personal Information Form, RLS Diagnosis Criteria Questionnaire, RLS Severity Rating Scale, Pittsburgh Sleep Quality Index, Post Application Follow-up Chart and Application Satisfaction Form.

While hot and cold water is applied in the intervention groups in the study, no application other than routine maintenance and follow-up will be done to the control group.Data analysis obtained in the research will be performed in TURCOSA statistical software (Turcosa Analytics Ltd Co, Turkey, www.turcosa.com.tr).In comparisons, a value of p <0.05 will be considered statistically significant.In order to conduct the study, the necessary Academic Committee decision, Ethics Committee approval (September 09, 2020 and number 2020/445) and institutional permission were obtained. The individuals included in the study will be informed about the purpose of the research, their verbal consent will be obtained and the participant's informed consent form will be signed.

Registry
clinicaltrials.gov
Start Date
September 30, 2020
End Date
September 30, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ozlem Kaplan

Reserch Asistant

TC Erciyes University

Eligibility Criteria

Inclusion Criteria

  • Least literate
  • between the weeks of gestation
  • Having a single pregnancy
  • The presence of RLS is detected according to the RLS Diagnostic Criteria Questionnaire
  • Having RLS due to pregnancy
  • Uses Iron, Vitamin D, Magnesium and Calcium
  • Pregnant women who have a severity of 11 or more according to the RLS Severity Rating Scale will be included in the study

Exclusion Criteria

  • Those who have a communication disability,
  • Risky pregnancy (Preterm labor risk, Cervical insufficiency, etc.),
  • Chronic disease (Diabetes, Hypertension, Thyroid, Cardiovascular disease, epilepsy, etc.),
  • With maternal obesity, BMI\> 30
  • He has heirs in his legs,
  • Pre-pregnancy sleep apnea,
  • Having any psychiatric disease and using antipsychotic, antidepressant medication,
  • Using antihistamine, antiepileptic, antiemetic, calcium channel blocker, dextromethorphan and decongestant type drugs,
  • Using heparin,
  • Pregnant women with a history of deep vein thrombosis, or atherosclerosis history or risk will not be included in the study.

Outcomes

Primary Outcomes

RLS Severity Rating Scale

Time Frame: change from baseline score at the end of one week

The RLS Severity Rating Scale was developed in 2003 by the International Restless Legs Syndrome Study Group. The scale was applied in the selection of patients and in the weekly evaluation of RLS severity. The scale comprised ten questions; each question was scored between 0 and 4. Questions 1, 2, 4, 6, 7, and 8 were related to RLS symptoms, questions 5, 9, and 10 were related to the effect of the disease on the mental state and daily social activities of patients with RLS, and question 3 was about the diagnostic criteria of RLS. The overall score indicated the RLS severity. A minimum score of 0 and a maximum score of 40 could be obtained. A score between 1 and 10 corresponded to "mild," 11-20 "moderate," 21-30 "severe," and 31-40 "very severe" RLS.

Secondary Outcomes

  • Pittsburgh Sleep Quality Index(change from baseline score at the end of one week)

Study Sites (1)

Loading locations...

Similar Trials